Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity - Concepedia

Concepedia

Publication | Open Access

Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity

DOI Full Paper Access

103

Citations

21

References

2020

Year

Yan Wang, Haiqing Ni, Shuaixiang Zhou, Kaijie He, Yarong Gao, Weiwei Wu, Min Wu, Zhihai Wu, Xuan Qiu, Ying Zhou,

Cancer Immunology Immunotherapy

Cancer ImmunosurveillanceMedicineImmunologyTumor ImmunityLimited ToxicityImmune Checkpoint InhibitorCd47/pd-l1 Bispecific AntibodyAnti-cancer AgentTumor TargetingImmunotherapyOncologyCell BiologyTumor-selective Blockade

References

	Year	Citations

Page 1

Page 1